Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 14, 2019 - Issue
Submit an article Journal homepage
79
Views
6
CrossRef citations to date
0
Altmetric
Original Research

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD

REK Russell1 Respiratory Medicine Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK;2 NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UKCorrespondence[email protected]
,
S Beer3 Department of Emergency Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
,
ID Pavord1 Respiratory Medicine Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK;2 NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK
,
R Pullinger3 Department of Emergency Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
&
M Bafadhel1 Respiratory Medicine Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
Pages 971-977 | Published online: 07 May 2019

References

  • Britton M. The burden of COPD in the U.K.: results from the confronting COPD survey. Respir Med. 2003;97 Suppl C:S71–S79.
  • West JB. GOLD executive summary. Am J Respir Crit Care Med. 2013;188:1366–1367.
  • National Institute for Health and Clinical Excellence. Chronic Obstructive Pulmonary Disease: Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care; 2013. Available from: https://www.nice.org.uk/guidance/ng115. Accessed December 17, 2018.
  • Connolly MJ. Admissions to hospital with exacerbations of chronic obstructive pulmonary disease: effect of age related factors and service organisation. Thorax. 2006;61:843–848.16928716
  • Garcia-Sanz MT, Pol-Balado C, Abellás C, et al. Factors associated with hospital admission in patients reaching the emergency department with COPD exacerbation. Multidiscip Respir Med. 2012;7:6.22958396
  • Yeatts, KB, Lippmann SJ, Waller AE, et al. Population-based burden of COPD-related visits in the ED: return ED visits, hospital admissions, and comorbidity risks. Chest. 2013;144:784–793.23579283
  • Dalal AA, Christensen L, Liu F, Riedel AA. Direct costs of chronic obstructive pulmonary disease among managed care patients. Int J Chron Obstruct Pulmon Dis. 2010;5:341–349.21037958
  • GOLD 2017 Global Strategy for the Diagnosis, Management and Prevention of COPD. Available from: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/. Accessed December 17, 2018.
  • Walters JA, Gibson PG, Wood-Baker R, Hannay M, Walters EH. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2009;CD001288. doi:10.1002/14651858.CD001288.pub319160195
  • Vollenweider DJ, Jarrett H, Steurer-Stey CA, Garcia-Aymerich J, Puhan MA. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2012;12:CD010257.23235687
  • Bafadhel M, McKenna S, Terry S, et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomised placebo-controlled trial. Am J Respir Crit Care Med. 2012;186:48–55. doi:10.1164/rccm.201108-1553OC22447964
  • Green, RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet. 2002;360:1715–1721.12480423
  • Brightling CE, Monteiro W, Ward R, et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2000;356:1480–1485. doi:10.1016/S0140-6736(00)02872-511081531
  • Berry M, Morgan A, Shaw DE, et al. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax. 2007;62:1043–1049. doi:10.1136/thx.2006.07342917356056
  • Bafadhel M, Greening NJ, Harvey-Dunstan TC, et al. Blood eosinophils and outcomes in severe hospitalised exacerbations of COPD. Chest. 2016;150:320–328. doi:10.1016/j.chest.2016.01.02626851799
  • Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012;67:970–976. doi:10.1136/thoraxjnl-2012-20176822895999
  • Anthonisen, NR, Manfreda J, Warren CP, Hershfield ES. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106:196–204.3492164
  • Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest. 2000;117:398S–401S.10843984
  • Koutsokera A, Kostikas K, Nicod LP, Fitting J-W. Pulmonary biomarkers in COPD exacerbations: a systematic review. Respir Res. 2013;14:111.24143945
  • Serafino-Agrusa L, Scichilone N, Spatafora M, Battaglia S. Blood eosinophils and treatment response in hospitalised exacerbations of chronic obstructive pulmonary disease: a case-control study. Pulm Pharmacol Ther. 2016;37:89–94.26996272
  • Couillard S, Larivee P, Courteau J, Vanasse A. Eosinophils in COPD exacerbations are associated with increased readmissions. Chest. 2017;151:366–373.27746201
  • Duman, D, Aksoy E, Agca MC, et al. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia. Int J Chron Obstruct Pulmon Dis. 2015;10:2469–2478.26648709
  • Steer J, Gibson GJ, Bourke SC. Predicting outcomes following hospitalisation for acute exacerbations of COPD. QJM. 2010;103:817–829.20660633

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.